Literature DB >> 20337777

Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period.

G Malm1, J-E Månsson.   

Abstract

AIM: The aim of this study was to present the natural clinical course in children and adolescents with MPS III diagnosed during a 30-year period in Sweden.
METHODS: The patients were identified from metabolic laboratory records between 1975 and 2004. Patient data were assessed from interviews of parents and by clinical examination and records from the patients.
RESULTS: A total of 15 children, 68%, with MPS IIIA were diagnosed at a median age of 6.8 years (range 1.2-18.9 years). One boy had MPS IIIB and five children MPS IIIC, diagnosed at ages between 1.9 and 11.6 years. In one child the type was not determined. The median age of children with type IIIA who had deceased was 16.2 years (range 10.4-31.2 years). Ten individuals with MPS III are alive at ages between 5 and 29 years. In four families, two children were affected.
CONCLUSION: In 22 Swedish children with Sanfilippo disease an early normal development followed by a delay in speech and an appearance of behaviour problems was found in most children during the early preschool period. Mental retardation was diagnosed in almost all individuals before starting school. Early diagnosis is important in this devastating, progressive disorder, not only for genetic counselling but also for participation in future treatments.

Entities:  

Mesh:

Year:  2010        PMID: 20337777     DOI: 10.1111/j.1651-2227.2010.01800.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  19 in total

1.  Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.

Authors:  Min-Sun Kim; Aram Yang; Eu-Seon Noh; Chiwoo Kim; Ga Young Bae; Han Hyuk Lim; Hyung-Doo Park; Sung Yoon Cho; Dong-Kyu Jin
Journal:  J Pers Med       Date:  2022-04-21

Review 2.  Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders.

Authors:  E M Cross; D J Hare
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

3.  Bone mineral density in patients with mucopolysaccharidosis type III.

Authors:  Banu Guzel Nur; Hakan Nur; Ercan Mihci
Journal:  J Bone Miner Metab       Date:  2016-05-18       Impact factor: 2.626

4.  Natural history of Sanfilippo syndrome type A.

Authors:  Dakota Buhrman; Kavita Thakkar; Michele Poe; Maria L Escolar
Journal:  J Inherit Metab Dis       Date:  2013-11-23       Impact factor: 4.982

5.  Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test.

Authors:  Alex Langford-Smith; Kia J Langford-Smith; Simon A Jones; Robert F Wynn; J E Wraith; Fiona L Wilkinson; Brian W Bigger
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

6.  Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome).

Authors:  Marlies J Valstar; Jan Pieter Marchal; Martha Grootenhuis; Vivian Colland; Frits A Wijburg
Journal:  Orphanet J Rare Dis       Date:  2011-06-20       Impact factor: 4.123

7.  Natural history of Sanfilippo syndrome in Spain.

Authors:  Verónica Delgadillo; Maria del Mar O'Callaghan; Laura Gort; Maria Josep Coll; Mercedes Pineda
Journal:  Orphanet J Rare Dis       Date:  2013-12-06       Impact factor: 4.123

8.  An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III.

Authors:  Elaine M Cross; Sheena Grant; Simon Jones; Brian W Bigger; James E Wraith; Louise V Mahon; Michelle Lomax; Dougal J Hare
Journal:  J Neurodev Disord       Date:  2014-12-31       Impact factor: 4.025

9.  Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.

Authors:  Sara Marcó; Anna Pujol; Carles Roca; Sandra Motas; Albert Ribera; Miguel Garcia; Maria Molas; Pilar Villacampa; Cristian S Melia; Víctor Sánchez; Xavier Sánchez; Joan Bertolin; Jesús Ruberte; Virginia Haurigot; Fatima Bosch
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

Review 10.  Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder.

Authors:  Frits A Wijburg; Grzegorz Węgrzyn; Barbara K Burton; Anna Tylki-Szymańska
Journal:  Acta Paediatr       Date:  2013-02-06       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.